Ammonia → N-(3-((2R,5S)-6-amino-3,3,5-trifluoro-2,5-dimethyl-2,3,4,5-tetrahydropyridin-2-yl)-4-fluorophenyl)-5-fluoropico linamide

HRID 530288

Reaktionsgleichung

Reaktionsgleichung von HRID 530288
[F:1][C:2]1[CH:3]=[CH:4][C:5]([C:8]([OH:10])=O)=[N:6][CH:7]=1.F[P-](F)(F)(F)(F)F.C[N:19](C(N(C)C)=[N+]1C2C(=NC=CC=2)[N+]([O-])=N1)C.[NH2:35][C:36]1[CH:37]=[CH:38][C:39]([F:54])=[C:40]([C@@:42]2([CH3:53])[NH:47][C:46](=S)[C@:45]([F:50])([CH3:49])[CH2:44][C:43]2([F:52])[F:51])[CH:41]=1.C(N(CC)C(C)C)(C)C.N>CN(C=O)C.C(OCC)(=O)C>[NH2:19][C:46]1[C@:45]([F:50])([CH3:49])[CH2:44][C:43]([F:52])([F:51])[C@:42]([C:40]2[CH:41]=[C:36]([NH:35][C:8](=[O:10])[C:5]3[CH:4]=[CH:3][C:2]([F:1])=[CH:7][N:6]=3)[CH:37]=[CH:38][C:39]=2[F:54])([CH3:53])[N:47]=1

Komponenten

8

Versuchsvorschrift

5-fluoropicolinic acid (269 mg, 1.906 mmol) and 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo-[4,5-b]pyridinium 3-oxid hexafluorophosphate (HATU) (797 mg, 2.10 mmol) were placed in a round bottom flask, dissolved in DMF (5.2 mL), and stirred at room temperature for 5 min. (3S,6R)-6-(5-amino-2-fluorophenyl)-3,5,5-trifluoro-3,6-dimethylpiperidine-2-thione (292 mg, 0.953 mmol) was added followed by N,N-diisopropylethylamine (830 μl, 4.77 mmol) and the reaction was stirred at room temperature for 5 min. The reaction was diluted with ethyl acetate (50 mL) and washed with a mixture of water (25 mL) and saturated aqueous NH4Cl (25 mL). The phases were separated and the aqueous layer was extracted with ethyl acetate (2×50 mL). The combined organics were dried over MgSO4, filtered, and concentrated under reduced pressure. The intermediate 5-fluoro-N-(4-fluoro-3-((2R,5S)-3,3,5-trifluoro-2,5-dimethyl-6-thioxopiperidin-2-yl)phenyl)picolinamide was purified using a CombiFlash system (40 g SiO2, gradient elution; heptanes:ethyl acetate 100:0→60:40). The intermediate (225 mg, 0.523 mmol) was split in two equal portions and placed in two separate reaction vials. Ammonia (14.6 mL, 102 mmol, 7 M in methanol) was also split in two equal portions and added to the two vials. The vials were capped and heated to 65° C. using an oil bath. After 6 h stirring at this temperature the reactions were allowed to cool to room temperature, the mixtures were combined and concentrated under reduced pressure. The crude material was subjected to silica-gel chromatography (eluent; heptane:ethyl acetate=50:50→0:100) to afford N-(3-((2R,5S)-6-amino-3,3,5-trifluoro-2,5-dimethyl-2,3,4,5-tetrahydropyridin-2-yl)-4-fluorophenyl)-5-fluoropico linamide (124 mg, 57% yield).

Aufarbeitung

  1. additionwas added
  2. washwashed with a mixture of water (25 mL) and saturated aqueous NH4Cl (25 mL)
  3. customThe phases were separated
  4. extractionthe aqueous layer was extracted with ethyl acetate (2×50 mL)
  5. dry with materialThe combined organics were dried over MgSO4
  6. filtrationfiltered
  7. concentrationconcentrated under reduced pressure
  8. customThe intermediate 5-fluoro-N-(4-fluoro-3-((2R,5S)-3,3,5-trifluoro-2,5-dimethyl-6-thioxopiperidin-2-yl)phenyl)picolinamide was purified
  9. washa CombiFlash system (40 g SiO2, gradient elution; heptanes:ethyl acetate 100:0→60:40)
  10. customseparate
  11. customreaction vials
  12. additionadded to the two vials
  13. customThe vials were capped
  14. temperatureheated to 65° C.
  15. stirringAfter 6 h stirring at this temperature the reactions
  16. temperatureto cool to room temperature
  17. concentrationconcentrated under reduced pressure

Quellen und Nachweise

ORD-Eintrag
ord-17a86bf2ed7e4ae2b0d4cd303805c0eb
Quelldatensatz
uspto-grants-2016_05
Patentnummer
US09353084B2

Verknüpfte Notizen

Wird geladen…